1. Nano-hesperetin enhances the functional recovery and endogenous remyelination of the optic pathway in focal demyelination model.
- Author
-
Baradaran S, Ghasemi-Kasman M, and Moghaddam AH
- Subjects
- Animals, Demyelinating Diseases physiopathology, Disease Models, Animal, Evoked Potentials, Visual drug effects, Evoked Potentials, Visual physiology, Hesperidin therapeutic use, Male, Optic Chiasm physiopathology, Rats, Rats, Wistar, Visual Cortex drug effects, Visual Cortex physiopathology, Visual Pathways physiopathology, Demyelinating Diseases drug therapy, Hesperidin pharmacology, Optic Chiasm drug effects, Recovery of Function drug effects, Remyelination drug effects, Visual Pathways drug effects
- Abstract
Our recent report demonstrated that hesperetin (Hst) as a citrus flavonoid, significantly reduces the levels of demyelination in optic chiasm of rats. Previous evidence also indicated that nano-hesperetin (nano-Hst) possesses beneficial impacts in experimental models of Alzheimer's disease and autism. In this study, the effects of nano-Hst on latency of visual signals, demyelination levels, glial activation, and expression of Olig2 and MBP were evaluated in lysolecithin (LPC)-induced demyelination model. Focal demyelination was induced by injection of LPC (1%, 2 μL) into the rat optic chiasm. Animals received oral administration of nano-Hst at dose of 20 mg/kg for 14 or 21 days post LPC injection. Visual evoked potential (VEP) recording showed that nano-Hst reduces the latency of visual signals and ameliorates the extent of demyelination areas and glial activation. Expression levels of the Olig2 and MBP were also significantly increased in nano-Hst treated rats. Overall, our data suggest that nano-Hst reduces the latency of visual signals through its protective effects on myelin sheath, amelioration of glial activation, and enhancement of endogenous remyelination., (Copyright © 2020 Elsevier Inc. All rights reserved.)
- Published
- 2020
- Full Text
- View/download PDF